Speaking to Daily News over the weekend, Government Chief Spokesperson and Permanent Secretary for the Ministry of ...

GDLS expects to deliver a prototype armed ARV-30 to the USMC for trials in 2025 following USMC directed and company-led tests and demonstrations of the C4/UAS ARV prototype in 2024.

DODOMA: THE Ministry of Health has dismissed reports circulating on social media about a shortage of antiretroviral ...

Announced that topline data from the monotherapy Phase 3 VERITAC-2 trial isanticipated in 1Q25 –– Presented Phase 1b data from the TACTIVE-U ...

Motsoaledi underscored South Africa's significant self-reliance in its HIV/AIDS programme while highlighting ongoing ...

Q4 2024 Earnings Call Transcript February 11, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.63, ...

the plans to present the first-in-human data for ARV-102 and the presentation of such data highlighting the potential value Arvinas’ PROTAC degraders can offer to patients with neurodegenerative ...

The deep-seated dysfunction and incompetence of Victoria’s city council was evident in all its glory when, rather than ...

Not only does the 35-year-old fear for his own survival as he takes life-saving anti-retroviral (ARV) drugs - but he says he ...

The Greater Chennai Corporation (GCC) plans to conduct a mass anti-rabies vaccination (ARV) drive on Sunday for all stray dogs in Velachery after seven, including a seven-month-old baby and a nine ...

CEO John Houston emphasized that Arvinas is nearing key milestones, including the first Phase 3 topline data for vepdegestrant (vepdeg) from the VERITAC-2 trial expected in Q1 2025. He noted that this ...

In Africa, a U.S. funding loss will be critical to HIV programs in countries like Uganda, Mozambique and Tanzania.